<aside> 💡 All historic Investor Updates, Friday Forums, and other inside the company content can be found here:
Inside Levels - Friday Forums and Investor Updates
August was a good month for us. We've continued to see customer excitement about the product, even in its rough form. We’re still testing a number of beta product concepts, the most promising of which is a dedicated app paired with a MMS-based chatbot-type interface.
We are charging $389 for our beta and we’ve been happy with the number of people that have signed up. We intend to hold revenue to around $5,000/mo while we continue with the beta, as we do not have the capacity to onboard more people while we are rapidly iterating on the product.
While not especially meaningful now since we’re in closed beta, revenue is the most important metric to track the health of the company going forward as we continue to refine the product. Our expected margin on each sale is approximately 60%-70%.
*$45,403 of the July burn is from legal fees related to setting up the physician network and FDA compliance documents and is not a repeat expense.